~~<i id='51B785ED1A'><strike id='51B785ED1A'><tt id='51B785ED1A'><pre id='51B785ED1A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：explore 2025-10-01 20:15:28 - browse：41947

Illustration of a road with a chasm in the middle, indicating the end of a deal or a problem with a deal — Adobe

A deal is never really done until it’s done.

On Tuesday, two different proposed insurance plan acquisitions on different sides of the country called it quits — one of them for the second time.

California-based Medicare Advantage insurer SCAN Group has been trying to buy CareOregon, an insurer offering coverage to half a million people in Oregon’s state health plan, since January 2023. National insurer Elevance has also been trying to buy Blue Cross and Blue Shield of Louisiana since last January. The on-again, off-again purchase was paused in September 2023 because of state regulators’ concerns, but was resubmitted with a slightly different plan in December.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： CMS should re

hotspot

Wikipedia

leisure time

focus

hotspot

Sen.BerneSanders(I-Vt.)KevinDietsch/GettyImagesWASHINGTON—Sen.BernieSanders(I-Vt.)hasanewcorporateta

WSS

H5N1 virus can be tracked in retail milk, scientists say

Eyeing GLP

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Cue Health, Covid

Patients' immediate access to test results puts radiologists in a bind

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

explore

hotspot

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Pfizer plans to depart BIO

Activists slam private health insurers over coverage restrictions

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

At least 13 dead in Texas as scorching temps continue

Why sickle cell disease is getting the first CRISPR treatment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

SCOTUS to consider access to abortion pill mifepristone

Drug repurposing or repositioning? The language matters

As a primary care physician, here's how I hope to partner with AI

Wikipedia

Scrutiny of post

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Teach medical students about patients with intellectual disabilities

Radiology is caught between AI's potential and concern for patients

Leukemia patients are helped by Syndax's new type of therapy

FDA approves world's first CRISPR

leisure time

focus

focus

hotspot